Wagner Wealth Management (South Carolina)’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-130
Closed -$1K – 605
2022
Q3
$1K Hold
130
– – ﹤0.01% 659
2022
Q2
$1K Buy
+130
New +$803 ﹤0.01% 675
2022
Q1
– Sell
-130
Closed -$2K – 564
2021
Q4
$2K Hold
130
– – ﹤0.01% 638
2021
Q3
$2K Hold
130
– – ﹤0.01% 606
2021
Q2
$3K Hold
130
– – ﹤0.01% 622
2021
Q1
$3K Buy
+130
New +$3.02K ﹤0.01% 591

Other funds holding RCEL

Wagner Wealth Management (South Carolina)'s RCEL Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of Avita Medical (RCEL) in Q4 2022, closing a stake of 130 shares — an estimated $1K sold.

Wagner Wealth Management (South Carolina) first reported a position in RCEL in Q1 2021 and held it in 6 quarters. The position peaked at $3K in Q2 2021. 51 funds tracked by Wall St. Rank hold RCEL as of Q4 2022.

  • Wagner Wealth Management (South Carolina) reported no remaining Avita Medical position as of Q4 2022 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 130 Avita Medical shares in Q4 2022, an estimated $1K.
  • Wagner Wealth Management (South Carolina) first reported a position in Avita Medical in Q1 2021 and held it in 6 quarters.
  • Wagner Wealth Management (South Carolina)'s Avita Medical position peaked at $3K in Q2 2021.
  • 51 funds tracked by Wall St. Rank held Avita Medical as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.